We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DEA Proposes Scaling Back National Manufacturing of Opioids and Other Controlled Drugs
DEA Proposes Scaling Back National Manufacturing of Opioids and Other Controlled Drugs
The Drug Enforcement Administration is proposing to lower its annual manufacturing limits on certain controlled substances for 2018 — which would cut back production of several classes of opioid painkillers and other scheduled pharmaceuticals, some between 10 and 25 percent.